ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #6,643Hybrid

Medical Microbiology and Immunology

Acronym:mmim
•
Abbreviation (ISO):MED MICROBIOL IMMUN
•
Identifier (ISSN):0300-8584(Print)/1432-1831(Online)
•
Publisher:Springer Berlin Heidelberg
Clarivate IF (2026)
3.1↑ +0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Medical Microbiology and Immunology

WoS Q3
13683.220182.9620191.9620203.420214.1520225.420235.52024320253.12026
Annual Impact Factor Metric
Current (2026):3.1
Scopus SJR & RankScopus Q2
0.823
#6,643

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
77

77 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate3.6%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
26articles/year
50.52% Gold OA•70.59% Original Research

Aims & Scope

Medical Microbiology and Immunology (MMIM) publishes key findings on all aspects of the interrelationship between infectious agents and the immune system of their hosts. The journal´s main focus is original research work on intrinsic, innate or adaptive immune responses to viral, bacterial, fungal and parasitic (protozoan and helminthic) infections and on the virulence of the respective infectious pathogens. MMIM covers basic, translational as well as clinical research in infectious diseases and infectious disease immunology. Basic research using cell cultures, organoid, and animal models are welcome, provided that the models have a clinical correlate and address a relevant medical question. The journal also considers manuscripts on the epidemiology of infectious diseases, including the emergence and epidemic spreading of pathogens and the development of resistance to anti-infective therapies, and on novel vaccines and other innovative measurements of prevention. The following categories of manuscripts will not be considered for publication in MMIM: submissions of preliminary work, of merely descriptive data sets without investigation of mechanisms or of limited global interest, manuscripts on existing or novel anti-infective compounds, which focus on pharmaceutical or pharmacological aspects of the drugs, manuscripts on existing or modified vaccines, unless they report on experimental or clinical efficacy studies or provide new immunological information on their mode of action, manuscripts on the diagnostics of infectious diseases, unless they offer a novel concept to solve a pending diagnostic problem, case reports or case series, unless they are embedded in a study that focuses on the anti-infectious immune response and/or on the virulence of a pathogen.

Topics Covered (Recognized by AI)
Medicine81.1%Biology58.2%Genetics34.7%Virology32.3%Immunology32.3%Microbiology30.5%Chemistry30.3%Biochemistry23.3%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

IMMUNOLOGY

Q3
Rank108/183
IndexSCIE
JCRSCIE2026

MICROBIOLOGY

Q3
Rank95/167
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q2
Rank79/183
IndexSCIE
JCISCIE2026

MICROBIOLOGY

Q2
Rank78/167
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.1
Articles / Year21
Total Citations3
2025
IF3
Articles / Year51
Total Citations106
2024
IF5.5
Articles / Year31
Total Citations174
2023
IF5.4
Articles / Year23
Total Citations209
2022
IF4.148
Articles / Year35
Total Citations654

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,643Scopus Q2SCImago Profile
Scopus Coverage:1971-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q2
0.823

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
3.06

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,344 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations244
3-Year Documents84
Citable Documents82

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate51.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ2
Immunology and AllergyQ2
Medicine (miscellaneous)Q2
Microbiology (medical)Q2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 3.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区IMMUNOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Medical Microbiology and Immunology (acronym: mmim, abbr: MED MICROBIOL IMMUN, ISSN: 0300-8584) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer Berlin Heidelberg in Germany since 1886. The periodical holds a Journal Impact Factor (JIF) of 3.10, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.823 (Q2), an H-index of 77.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 26 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,344 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer Berlin Heidelberg
Publication Language
English
Frequency
Quarterly
Founding Year
1886
Indexing & Databases
SCIEScopusPubMed
Editorial Address
SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: da3f3c1c-f68f-492f-95d5-7aad6fccc26e
Database Updated: 2026-10-01